Survivorship and Outcomes of Robotic-Arm Assisted Medial Unicompartmental Knee Arthroplasty

Status unconfirmed

Conditions studied: Osteoarthritis

In brief

The purpose of the study is to determine the survivorship of robotic-arm assisted MCK medial onlay Unicompartmental knee arthroplasty implants at two, five and tem year follow up.

Key facts

Study ID

NCT03668717

Run by

St. Helena Hospital Coon Joint Replacement Institute

People needed

133

Starts

2011-10-01

Expected to finish

2026-04-01

Last updated by the study team

2018-09-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients over 21 years of age who underwent primary robotic-arm assisted unicompartmental arthroplasty and received a medial MCK onlay implant and are at least 24 months post-operative.
• Patient has signed an IRB approved Informed Consent Form or with IRB approved waiver of written consent, patient has verbally consented to study participations.
• Patient willing to comply with follow up.

You may not qualify if…

• Patient will be excluded from participation in the study if they are cognitively unable to answer questions related to their index procedure and health related quality of life forms.
• Patient had active infection
• Medial MCK onlay implants were implanted without bone cement
• Patients did not have sufficient bone stock to allow for insertion and fixation of components
• Patient did not have sufficient soft tissue integrity to allow for stability
• Patient had a neurological or muscular deformity that did not allow for control of the knee.

Where it is running

• St. Helena Hospital Coon Joint Replacement Institute — St. Helena, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.